Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial

Autor: Zeiser, Robert, Socié, Gérard, Schroeder, Mark A, Abhyankar, Sunil, Vaz, Carlos Pinho, Kwon, Mi, Clausen, Johannes, Volodin, Leonid, Giebel, Sebastian, Chacon, Manuel Jurado, Meyers, Gabrielle, Ghosh, Monalisa, Deeren, Dries, Sanz, Jaime, Morariu-Zamfir, Rodica, Arbushites, Michael, Lakshminarayanan, Mani, Barbour, April M, Chen, Yi-Bin *
Zdroj: In The Lancet Haematology January 2022 9(1):e14-e25
Databáze: ScienceDirect